Cases
Representative Matters: Mergers
Acquisitions: Represented Piramal Pharma Solutions in connection with its acquisition of a 221,000 square foot GMP oral solid dose manufacturing facility from G&W Laboratories.
Represented Almirall S.A. in connection with its acquisition of Allergan's U.S. dermatology products portfolio for an aggregate purchase price of $650 million.
Represented Almirall S.A. in connection with an Option Agreement for Almirall to acquire Bioniz Therapeutics, a biopharmaceutical company focused on the development of peptide treatments to treat immuno-inflammatory diseases.
Represented a national pharmacy in a transaction that granted an option to purchase the client's business for an aggregate purchase price of $230 million.
Represented Sancoa International Company
TubeDec, LLC, family owned affiliated companies that manufacture
supply products to Home & Personal Care customers in North America, in their $71 million sale to CCL Industries, a Canadian public company.
Represented Clarion Capital Partners, a New York private equity firm, in connection with the sale of Strategic Outsourcing, Inc., a human resources outsourcing firm, to TriNet Group, Inc.
Represented Sunoco Inc. in the sale of its polypropylene business, Sunoco Chemicals Inc., to Braskem SA for $350 million.
Represented Clarion Capital Partners, a New York private equity firm, in connection with the sale of Hartmann Luggage to Samsonite.
Represented Centocor, Inc. in connection with the $37 million sale of its worldwide oncology diagnostic business to Fujirebio Inc., a Japanese corporation.
Represented Centocor, Inc. in connection with the sale of its diagnostic infectious disease business in Engl
to Trinity Biotech plc, an Irish company.
Represented J.C. Ehrlich Co. Inc. in connection with the sale of its business to Rentokil Initial plc, a publicly traded UK company, for $142 million.
Represented Philadelphia Macaroni Co. in connection with its purchase of a pasta-manufacturing plant from Campbell Soup Co.
the negotiation of a 10-year supply agreement for pasta products with Campbell Soup.
Represented a privately owned cable television system in connection with its $90 million sale to another privately owned cable television system.
Represented a specialty pharmaceutical company in connection with a $106 million sale of its business to a private equity fund.
Represented Empire Education Group in connection with the merger of its accredited cosmetology schools with the accredited cosmetology schools of Regis Corp., a publicly traded company.
Represented Fujirebio Diagnostics Inc. in connection with its acquisition of all of the assets of American Biological Technologies in Seguin, Texas.
Represented Fujirebio Diagnostics Inc. in connection with its acquisition of CanAg Diagnostics Ab, a biotechnology manufacturing firm in Gothenburg, Sweden.
Represented Clarion Capital Partners in connection with its purchase of Hartmann Luggage from Brown-Foreman Corp.
Represented American Refining Co. in connection with the sale of its transmix business to Buckeye Pipeline Co.
Represented Hydac International GmbH, a German company, in connection with its acquisition of the filtration
mining-products division of Alco Industries, Inc.
Represented Satelec Pierre Rol
, a French manufacturer of dental products, in connection with the purchase of its U.S. distributor.
Represented Octagen Investor Partnership, a U.S. pharmaceutical research
development company, in connection with the sale of all of its assets to a wholly owned subsidiary of Ipsen SA, a publicly traded French company.
Represented a Pennsylvania private equity firm in connection with the acquisition of all the outst
ing shares of UniRisX, Limited, a UK software-as-service company focused on the international insurance market.
Commercial Transactions: Counsel to Almirall S.A. in connection with license agreements with Paratek Pharmaceuticals, Inc. pursuant to which Almirall will have the exclusive rights to develop, manufacture
commercialize sarecycline products in the U.S.
the greater China region,
Paratek will have the exclusive rights to develop, manufacture
commercialize sarecycline products in the other countries of the world.
Counsel to Centocor, Inc. in connection with an investment agreement
sales-
-distribution agreement with Eli Lilly
Co. regarding the development
distribution of two of Centocor's pharmaceutical products. The transaction resulted in Eli Lilly making a $100 million investment in equity
product development of Centocor.
Counsel to Centocor, Inc. in connection with its strategic alliance in the area of cancer therapy with The Wellcome Foundation
Burroughs Wellcome. The strategic alliance resulted in Wellcome making a $30 million initial equity
product rights investment in Centocor, with additional milestone payments of up to $70 million possible.
Counsel to Sunoco, Inc. in connection with a cogeneration agreement with Florida Power & Light for the construction of a 700 MW gas-fired electrical generating facility at Sunoco's refinery in Marcus Hook, Pa.,
a ground lease with Florida Power & Light for the construction of a gas-fired electrical generating facility at Sunoco's Philadelphia refinery.
Counsel to Fujirebio Diagnostics, Inc. in connection with its product development
manufacturing agreements with Abbott Laboratories.
Counsel to Targeted Diagnostics & Therapeutics, Inc., a privately owned biotechnology research
development company, in connection with an investment agreement
a development-
-license agreement with Millennium Pharmaceuticals, Inc. pursuant to which Millennium made an equity investment in Targeted Diagnostics,
Targeted Diagnostics granted an exclusive license to Millennium under certain patents
other intellectual property for uses in oncology therapeutics.
Counsel to Fujirebio Diagnostics, Inc. in connection with its product development
manufacturing agreements with Becton Dickinson.
Counsel to Targeted Diagnostics & Therapeutics, Inc., a privately owned biotechnology research
development company, in connection with a license
development agreement with Nycomed Imaging AS, a Norwegian corporation, for the development of a molecule for certain in vivo diagnostic imaging
therapeutic uses.
Counsel to the Atlantic 10 Conference, an intercollegiate athletic conference, in connection with a television-rights agreement with TFN, the Football Network, for the production
telecast of conference football games.
Counsel to the Atlantic 10 Conference, an intercollegiate athletic conference, in connection with agreements with ESPN, Inc., the sports cable network, providing for the telecast of the conference's regular season
playoff basketball games.
